Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 4,706 | 0 | 0 | 0 | 0 |
| Gross Profit | 4,706 | N/A | N/A | N/A | N/A |
| Operating Expenses | 21,265 | 56,468 | 25,457 | 33,373 | 49,651 |
| Operating Income | -16,559 | -53,966 | -25,457 | -33,373 | -49,651 |
| Interest Expense | 1,374 | 1,305 | 1,078 | 743 | 672 |
| Other Income | 311 | 193 | 8 | 24 | 6 |
| Pre-tax Income | -17,622 | -55,078 | -26,527 | -34,092 | -50,317 |
| Net Income Continuous | -17,622 | -55,078 | -26,527 | -34,092 | -50,317 |
| Net Income | $-17,622 | $-55,078 | $-26,527 | $-34,092 | $-50,317 |
| EPS Basic Total Ops | -0.28 | -0.96 | -0.65 | -0.85 | -1.32 |
| EPS Basic Continuous Ops | -0.28 | -0.96 | -0.65 | -0.85 | -1.32 |
| EPS Diluted Total Ops | -0.28 | -0.96 | -0.65 | -0.85 | -1.32 |
| EPS Diluted Continuous Ops | -0.28 | -0.96 | -0.65 | -0.85 | -1.32 |
| EBITDA(a) | $-16,228 | $-56,106 | $-25,180 | $-33,100 | $-49,391 |